바이오솔루션
5,920KRWMarket close of 10/20 (Tue)
Down -0.34%-20KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)5,890KRWDown -0.51%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 5,900
- High
- 6,100
- Low
- 5,740
- Day range
- Day range low 5,740 high 6,100, open 5,900, close 5,920, previous close 5,940
- Volume
- 3×10K shares
- 177.50 million KRW 0.45× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
6%6% of the way up from the lowest close in 1 year (252 sessions) · -54.3% from the high
Usual range
Nothing unusual in the 3 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move-0.34%usual range
- Trading value0.5×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue3.8B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating income-1.3B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating margin-34.5%
- vs. year ago
- —
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.